Skip to content
Disclosery

ORBIMED ADVISORS LLC: BSX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on BSX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 1,483,200 BSX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,483,200 shares
    Change vs previous 13F -898,900 shares

    1.2% of the 13F portfolio, value $63,302,976.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,382,100 shares
    Change vs previous 13F -37,200 shares

    3.26% of the 13F portfolio, value $149,476,775.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,419,300 shares
    Change vs previous 13F -10,000 shares

    4.72% of the 13F portfolio, value $230,680,255.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,429,300 shares
    Change vs previous 13F -383,900 shares

    5.69% of the 13F portfolio, value $237,172,559.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,813,200 shares
    Change vs previous 13F 0 shares

    7.6% of the 13F portfolio, value $302,165,812.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,813,200 shares
    Change vs previous 13F -347,100 shares

    6.82% of the 13F portfolio, value $283,795,616.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 3,160,300 shares
    Change vs previous 13F -112,700 shares

    5.86% of the 13F portfolio, value $282,277,996.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 3,273,000 shares
    Change vs previous 13F not available

    5.02% of the 13F portfolio, value $274,277,400.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).